Clinical Trial Update: Study to Compare a Mono Atezolizumab Window Followed by a Atezolizumab - CTX Therapy With Atezolizumab - CTX Therapy [Phase 2]

View source ↗

Summary

A Phase 2 trial comparing a mono atezolizumab window followed by atezolizumab–cyclophosphamide therapy versus atezolizumab–cyclophosphamide therapy in triple-ne…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Triple-negative Breast Cancer

Drugs mentioned

• Atezolizumab (atezolizumab)
• CYCLOPHOSPHAMIDE (Cyclophosphamide)

Snippet

Sponsor: Palleos Healthcare GmbH | Conditions: Triple-negative Breast Cancer | Phase 2 | Status: TERMINATED | Results posted: 2026-01-12